495 related articles for article (PubMed ID: 32594286)
41. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
42. Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.
Jia G; Wen W; Massion PP; Shu XO; Zheng W
Carcinogenesis; 2021 Jun; 42(6):874-879. PubMed ID: 33640962
[TBL] [Abstract][Full Text] [Related]
43. Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.
Potter AL; Xu NN; Senthil P; Srinivasan D; Lee H; Gazelle GS; Chelala L; Zheng W; Fintelmann FJ; Sequist LV; Donington J; Palmer JR; Yang CJ
J Clin Oncol; 2024 Jun; 42(17):2026-2037. PubMed ID: 38537159
[TBL] [Abstract][Full Text] [Related]
44. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
45. Selection of individuals for lung cancer screening based on risk prediction model performance and economic factors - The Ontario experience.
Tammemägi MC; Darling GE; Schmidt H; Llovet D; Buchanan DN; Leung Y; Miller B; Rabeneck L
Lung Cancer; 2021 Jun; 156():31-40. PubMed ID: 33887677
[TBL] [Abstract][Full Text] [Related]
46. 'Reduced' HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial.
Røe OD; Markaki M; Tsamardinos I; Lagani V; Nguyen OTD; Pedersen JH; Saghir Z; Ashraf HG
BMJ Open Respir Res; 2019; 6(1):e000512. PubMed ID: 31803478
[TBL] [Abstract][Full Text] [Related]
47. Risk-Based lung cancer screening: A systematic review.
Toumazis I; Bastani M; Han SS; Plevritis SK
Lung Cancer; 2020 Sep; 147():154-186. PubMed ID: 32721652
[TBL] [Abstract][Full Text] [Related]
48. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
[TBL] [Abstract][Full Text] [Related]
49. Examination of Chronic Smoking Behavior and Eligibility for Low-Dose Computed Tomography for Lung Cancer Screening Among Older Chinese Male Smokers.
Li CC; Matthews AK; Dong X
J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(suppl_1):S22-S25. PubMed ID: 28575258
[TBL] [Abstract][Full Text] [Related]
50. Assessing Different Approaches to Leveraging Historical Smoking Exposure Data to Better Select Lung Cancer Screening Candidates: A Retrospective Validation Study.
Kats DJ; Adie Y; Tlimat A; Greco PJ; Kaelber DC; Tarabichi Y
Nicotine Tob Res; 2021 Aug; 23(8):1334-1340. PubMed ID: 32974635
[TBL] [Abstract][Full Text] [Related]
51. Comparison of discrimination performance of 11 lung cancer risk models for predicting lung cancer in a prospective cohort of screening-age adults from Germany followed over 17 years.
Bhardwaj M; Schöttker B; Holleczek B; Brenner H
Lung Cancer; 2022 Dec; 174():83-90. PubMed ID: 36356492
[TBL] [Abstract][Full Text] [Related]
52. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
53. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.
Lowry KP; Gazelle GS; Gilmore ME; Johanson C; Munshi V; Choi SE; Tramontano AC; Kong CY; McMahon PM
Cancer; 2015 May; 121(10):1556-62. PubMed ID: 25652107
[TBL] [Abstract][Full Text] [Related]
54. Benefits and Challenges of Lung Cancer Screening in Older Adults.
Fabrikant MS; Wisnivesky JP; Marron T; Taioli E; Veluswamy RR
Clin Ther; 2018 Apr; 40(4):526-534. PubMed ID: 29573852
[TBL] [Abstract][Full Text] [Related]
55. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
[TBL] [Abstract][Full Text] [Related]
56. Medicare Approves Coverage for Lung Cancer Screening: The Case for Symptomatic Screening.
Verma V; Beriwal S
JAMA Oncol; 2015 Nov; 1(8):1027-8. PubMed ID: 26226384
[No Abstract] [Full Text] [Related]
57. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
58. Variations in lung cancer risk among smokers.
Bach PB; Kattan MW; Thornquist MD; Kris MG; Tate RC; Barnett MJ; Hsieh LJ; Begg CB
J Natl Cancer Inst; 2003 Mar; 95(6):470-8. PubMed ID: 12644540
[TBL] [Abstract][Full Text] [Related]
59. Stratification and management of patients ineligible for lung cancer screening.
Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G
Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536
[TBL] [Abstract][Full Text] [Related]
60. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
